174 related articles for article (PubMed ID: 20680238)
1. [Brachytherapy for the treatment of head and neck cancer].
Meyer JE; Brocks C; Maune S; Strnad V; Werner JA; Wollenberg B; Kovács G
HNO; 2010 Sep; 58(9):947-58. PubMed ID: 20680238
[TBL] [Abstract][Full Text] [Related]
2. Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.
Kovács G
J Contemp Brachytherapy; 2015 Jan; 6(4):404-16. PubMed ID: 25834586
[TBL] [Abstract][Full Text] [Related]
3. Perioperative image-adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies.
Teudt IU; Meyer JE; Ritter M; Wollenberg B; Kolb T; Maune S; Kovàcs G
Brachytherapy; 2014; 13(2):178-86. PubMed ID: 24210698
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
[TBL] [Abstract][Full Text] [Related]
5. The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck.
Wierzbicka M; Bartochowska A; Strnad V; Strojan P; Mendenhall WM; Harrison LB; Rinaldo A; Sahai P; Wiegand S; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):269-76. PubMed ID: 25338181
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer.
Nag S; Schuller D; Pak V; Young D; Grecula J; Bauer C; Samsami N
Radiother Oncol; 1996 Nov; 41(2):125-30. PubMed ID: 9004354
[TBL] [Abstract][Full Text] [Related]
7. Second-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol.
Ritter M; Teudt IU; Meyer JE; Schröder U; Kovács G; Wollenberg B
Radiat Oncol; 2016 Jan; 11():6. PubMed ID: 26792072
[TBL] [Abstract][Full Text] [Related]
8. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.
Mazeron JJ; Ardiet JM; Haie-Méder C; Kovács G; Levendag P; Peiffert D; Polo A; Rovirosa A; Strnad V
Radiother Oncol; 2009 May; 91(2):150-6. PubMed ID: 19329209
[TBL] [Abstract][Full Text] [Related]
9. GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
Kovács G; Martinez-Monge R; Budrukkar A; Guinot JL; Johansson B; Strnad V; Skowronek J; Rovirosa A; Siebert FA;
Radiother Oncol; 2017 Feb; 122(2):248-254. PubMed ID: 27889184
[TBL] [Abstract][Full Text] [Related]
10. Applications of brachytherapy in head and neck cancer.
Harrison LB
Semin Surg Oncol; 1997; 13(3):177-84. PubMed ID: 9143055
[TBL] [Abstract][Full Text] [Related]
11. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
12. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Cesium-131 Brachytherapy for Patients Intolerant of External Beam Radiation Therapy.
Sagheer SH; Bornstein J; Bar-Ad V; Cheng M; Cummins A; Cognetti DM; Curry J; Yao M; Lavertu P; Kutler DI; Zender C; Luginbuhl AJ
Laryngoscope; 2021 Aug; 131(8):E2449-E2451. PubMed ID: 33729580
[No Abstract] [Full Text] [Related]
15. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies.
Takácsi-Nagy Z; Martínez-Mongue R; Mazeron JJ; Anker CJ; Harrison LB
Brachytherapy; 2017; 16(1):44-58. PubMed ID: 27592129
[TBL] [Abstract][Full Text] [Related]
16. [Brachytherapy of head and neck cancer].
Takácsi Nagy Z; Kásler M
Magy Onkol; 2008 Jun; 52(2):145-50. PubMed ID: 18640890
[TBL] [Abstract][Full Text] [Related]
17. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
Strnad V; Lotter M; Kreppner S; Fietkau R
Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
[TBL] [Abstract][Full Text] [Related]
18. Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.
Li CX; Gong ZC; Zhang WN; Zhang Y; Zhao HR
Oral Maxillofac Surg; 2024 Jun; 28(2):547-555. PubMed ID: 37935817
[TBL] [Abstract][Full Text] [Related]
19. Function Preservation in Head and Neck Cancers.
Budrukkar A; Guinot JL; Tagliaferri L; Bussu F; García-Consuegra A; Kovacs G
Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):497-506. PubMed ID: 36849321
[TBL] [Abstract][Full Text] [Related]
20. Brachytherapy for radiotherapy-resistant head and neck cancer: A review of a single center experience.
Hazkani I; Rabinovics N; Limon D; Silvern D; Koren S; Hadar T; Bachar G; Shpitzer T; Popovtzer A
Laryngoscope; 2016 Oct; 126(10):2246-51. PubMed ID: 26928864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
